APA (7th ed.) Citation

AA, L., S, P., D, B., D, M., M, M., AL, F., . . . P, G. (2026). Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with metabolic dysfunction-associated steatotic liver disease. Annals of hepatology, 102206. https://doi.org/10.1016/j.aohep.2026.102206

Chicago Style (17th ed.) Citation

AA, Laraño, et al. "Fibulin-3 as a Reliable Biomarker of Fibrosis in Obese Subjects with Metabolic Dysfunction-associated Steatotic Liver Disease." Annals of Hepatology 2026: 102206. https://doi.org/10.1016/j.aohep.2026.102206.

MLA (9th ed.) Citation

AA, Laraño, et al. "Fibulin-3 as a Reliable Biomarker of Fibrosis in Obese Subjects with Metabolic Dysfunction-associated Steatotic Liver Disease." Annals of Hepatology, 2026, p. 102206, https://doi.org/10.1016/j.aohep.2026.102206.